TNF and glycogen storage disease VI: -Treatment includes anti-inflammatory therapies and proper wound care -First-line: fast-acting immunosuppressive drugs including topical or systemic corticosteroids and/or cyclosporine-Second-line: infliximab, other biologic TNF-α inhibitors, dapsone, minocycline -Refractory disease: IV immune globulin and alkylating agents